Want to see BDTX full AI Analyst Report?
Black Diamond Therapeutics (BDTX) Q2 2024 Earnings Report
BDTX Q2 2024 EPS Results
- Actual EPS
- -$0.36
- Consensus EPS
- -$0.39
- Beat/Miss
- Beat by +$0.03
- One Year Ago EPS
- -$0.52
BDTX Q2 2024 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/06/2024
- Time
- Before Open
- Conference Call
- Tuesday, August 6, 2024
BDTX Upcoming Earnings
Black Diamond Therapeutics's next earnings date is estimated for November 9, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
BDTX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 09, 2026 | 2026 (Q3) | -0.09- | -0.15 | ― | ― |
| Aug 05, 2026 | 2026 (Q2) | -0.20-0.17 | -0.19 | 10.53% (+0.02) | |
| May 07, 2026 | 2026 (Q1) | -0.18-0.16 | 0.98 | -116.33% (-1.14) | |
| Mar 16, 2026 | 2025 (Q4) | -0.18-0.27 | -0.28 | 3.57% (+0.01) | |
| Nov 06, 2025 | 2025 (Q3) | -0.23-0.15 | -0.28 | 46.43% (+0.13) | |
| Aug 07, 2025 | 2025 (Q2) | -0.25-0.19 | -0.36 | 47.22% (+0.17) | |
| May 12, 2025 | 2025 (Q1) | 0.020.98 | -0.35 | 380.00% (+1.33) | |
| Mar 06, 2025 | 2024 (Q4) | -0.32-0.28 | -0.34 | 17.65% (+0.06) | |
| Nov 05, 2024 | 2024 (Q3) | -0.37-0.28 | -0.45 | 37.78% (+0.17) | |
| Aug 06, 2024 | 2024 (Q2) | -0.39-0.36 | -0.52 | 30.77% (+0.16) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
